Multiple sclerosis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Having a proven MS condition based on clinical examination and medical history Confirmation of tremor based on neurologist approval based on clinical criteria Having an EDSS score between 2 and 6 Having fixed and regular consumption of medication in the last 3 months Consent to not use alternative drugs from 7 days before the intervention until the end of the intervention No attending to another study at the same time
Exclusion criteria
Exclusion criteria: History of alcohol use or substance abuse Pregnancy or breastfeeding Impaired renal or hepatic function Steroid treatment during the month before the start of the study Having a neurological disease in addition to MS Heart disease or bleeding disorders Existence of allergy to Nigella Sativa The onset of the disease in the last month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tremor Amplitude. Timepoint: Tremor amplitude measurement at the beginning of the study and six weeks after taking soft capsule Nigella Sativa. Method of measurement: Video motion recording system.;Tremor frequency. Timepoint: Tremor frequency measurement at the beginning of the study and six weeks after taking soft capsule Nigella Sativa. Method of measurement: Video motion recording system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the beginning of the study and six weeks after taking soft capsule Nigella Sativa. Method of measurement: Questionnaire quality of life.;Frequency of drug side effects. Timepoint: At the beginning of the study and six weeks after taking soft capsule Nigella Sativa. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences